| ABC | Adenosine Triphosphate-Binding Cassette |
| ACSVL1 | Acyl-CoA synthetase 1 |
| ADEs | Adverse Events |
| AHA | American Heart Association |
| AMI | Acute Myocardial infarction |
| ANGPTLs | Angiopoietin-like proteins |
| ApoB | Apolipoprotein B |
| ApoC-III | Apolipoprotein C-III |
| ASCVD | Atherosclerotic Cardiovascular Disease |
| BA | Bempedoic Acid |
| CABG | Coronary Artery Bypass Grafting |
| CCS | Chronic Coronary Syndrome |
| CV | Cardiovascular |
| CVD | Cardiovascular Disease |
| EMA | European Medicines Agency |
| ESC | European Society of Cardiology |
| FDA | Food and Drug Administration |
| FCS | Familial Chylomicronemia Syndrome |
| FH | Familial Hypercholesterolemia |
| HDL-C | High-Density Lipoprotein Cholesterol |
| HMG-CoA | 3-Hydroxy-3-Methylglutaryl-Coenzyme A |
| HeFH | Heterozygous Familial Hypercholesterolemia |
| HoFH | Homozygous Familial Hypercholesterolemia |
| hs-CRP | High-Sensitivity C-Reactive Protein |
| IDL | Intermediate-Density Lipoprotein |
| IVUS | Intravascular Ultrasonography |
| LDL-C | Low-Density Lipoprotein Cholesterol |
| LDL-R | LDL-Receptors |
| Lp(a) | Lipoprotein(a) |
| LPL | Lipoprotein Lipase |
| LXRs | Liver X Receptors |
| MOA | Mechanism of Action |
| MTP | Microsomal Triglyceride Transfer Protein |
| NIRS | Near-Infrared Spectroscopy |
| OCT | Optical Coherence Tomography |
| PPARs | Peroxisome Proliferator-Activated Receptors |
| PCI | Percutaneous Coronary Intervention |
| PCSK9i | Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors |
| RCT | Randomized Clinical Trial |
| ReCT | Reverse Cholesterol Transport |
| SI | Statin Intolerance |
| siRNA | Small Interfering RNA |
| TG | Triglycerides |
| TRL | Triglycerides Rich Lipoproteins |
| VLDL | Very-Low-Density Lipoproteins |